Dr. Bansal is global consultant for regulated bioanalysis. His working experience in the field of bioanalysis has been both in the Pharmaceutical companies (recently at Roche for 20 years and previously at American Cyanamid for 5 years) and contract research organizations (combined 4 years in 2 organizations). During this period he has worked on both, small and large molecules bioanalysis; supporting studies from drug discovery to regulatory drug development and marketing. He has developed and validated numerous bioanalytical methods using various cutting edge technologies. In a span of over 25 years in bioanalysis, he developed strategies for enhancing technologies, gaining efficiency, quality and regulatory compliance in bioanalytical work. He is globally active in several bioanalytical organizations, e.g., as an executive member and past-chair of the AAPS Bioanalytical Focus Group, founding member of the Global Bioanalytical Consortium (GBC). He has given lectures at numerous international conferences and has chaired several symposia and conferences, including AAPS Crystal City III bioanalytical workshop, AAPS conference on analytical instrument qualification (AIQ) and APA regulated bioanalysis workshop. He has published over 65 articles, book chapters and abstracts in bioanalytical and related fields.